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Abstract 
Background: The prescribing of opioids has increased internationally in developed 
countries in recent decades within primary and secondary care.1 The majority of patients 
with chronic non-malignant pain (CNMP) are managed by their GP.2 Recent qualitative 
studies have examined the issue of opioid prescribing for chronic non-malignant pain 
(CNMP) from a GP viewpoint. Several factors have been reported to influence the 
prescribing of opioids for CNMP including aetiology of pain condition, co-morbidities, 
access to specialised care, history of drug abuse and professional scrutiny.  We require 
a better understanding of problems GP’s face when making opioid prescribing decisions,  
and interventions to provide better supports in the prescribing of opioids for CNMP. The 
aim of this study is to identify and synthesize the qualitative literature describing the 
factors influencing the nature and extent of opioid prescribing in CNMP in primary care. 
A theoretical model is then proposed which seeks to explain the relationship between 
factors influencing prescribing of opioids for CNMP by GPs. 
Methods: MEDLINE, Embase, PsychINFO, Cochrane Database, International 
Pharmaceutical Abstracts, Database of Abstracts of Reviews of Effects, CINAHL and 
Web of Science were systematically searched from January 1986- Feb 2018. Studies that 
documented GP’s experiences and behaviours relating to prescribing opioids for chronic 
non-malignant pain in a primary care setting were included. Two reviewers independently 
screened titles and abstracts. Studies were excluded from the review if they were non-
English language, theoretical or methodological articles, policy documents, conference 
abstracts or presentations, as or where quotations were not clearly attributed to GPs 
participating in the study. Two reviewers independently screened all titles and abstracts. 
The reviewers then independently assessed the full text of the articles using the Critical 
Appraisal Skills Programme (CASP) tool for qualitative research. The papers were coded 
by two researcher and these codes organised using Thematic Network Analysis. Basis 
themes were defined initially, organising themes were then developed followed by global 
themes which summarised the key theories emerging from the articles. Finally, a 
theoretical model was derived by the researchers using the global themes to explain the 
interplay between factors influencing opioid prescribing decisions. 
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Results: From 7020 records, 18 full text papers were assessed, and 13 studies included 
in the synthesis; 9 were from USA, 3 from UK and 1 from Sweden. Seven organising 
themes were identified including trust and mistrust, the importance of aetiology, 
monitoring of prescription use, physical, psychological and societal harm, consultation 
variables, inadequate pain management, stigma and stereotypes and system barriers to 
effective and safe prescribing such as limited access to specialist care or support from 
allied healthcare professionals in primary care. Four global themes emerged and included 
suspicion, risk, agreement and encompassing systems level factors. These global themes 
are inter-related and capture the complex decision-making processes underlying the 
opioid prescribing whereby the physician both consciously and subconsciously quantifies 
the risk-benefit relationship associated with initiating or continuing an opioid prescription. 
Conclusion: Prescribing of opioids for CNMP is influenced by a myriad of factors. Rather, 
than a simple risk-benefit view of the process, it is more useful to view this as a dynamic 
process in which unique considerations such as the morality of opioid use exert an effect. 
Recognising the inherent complexity of the process and the limitations of healthcare 
systems, guidelines directed at GPs should offer more nuanced recommendations on 
managing opioid prescribing consultations in primary care. 
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Introduction 
Worldwide prevalence of prescription opioid use has tripled since 1991, the greatest 
increases occurring in the USA and Canada 3-5. Recent UK studies have highlighted an 
increase in the prescribing of opioids in primary care, most prominent in areas of social 
deprivation.1, 6-8 These patterns have emerged despite lack of evidence of efficacy of 
opioids when used in the long-term but clear evidence of dose-dependent harmful 
outcomes for patients.9  
Prescribing medication regardless of the condition being managed is a complex 
process as it requires the GP to consolidate evidence based recommendations with the 
patient’s presenting complaint and co-morbidities to recommend a course of action having 
reached a consensus with the patient.10  GP-patient encounters centred on the 
prescribing of opioids are particularly complex given the potential for adverse outcomes 
from these medications and the understandable concern about potentially inappropriate 
use and addiction. However, being overly-cautious can result in the under-prescribing  of 
analgesics particularly in medically complicated patients, this which can lead to 
uncontrolled pain with a negative impact on quality of life.11 
Several qualitative studies have sought to describe the factors influencing GP opioid 
prescribing decisions. These studies have indicated that the prescribing of opioids for 
chronic non-malignant pain (CNMP) in primary care is influenced by the resources 
available to the GP in addition to knowledge, experience and beliefs of the prescriber may 
influence prescribing practices. For instance, ease of access to physiotherapy or pain 
specialists, perceived or actual risk of opioid related side-effects, concerns about misuse 
of opioids and professional experience in the management of CNMP are factors that 
alone or in combination influence the decision making process. 12-14 These issues may 
be further compounded by a sense of scrutiny from professional authorities which may 
further influence their approach to practice. 15 
As most opioids prescriptions are initiated by a patient’s GP, it is essential that we 
understand the dynamics of a GP-patient consultation which lead to the prescribing 
decision. 1 The aim of this study is to identify and synthesize the qualitative literature on 
the factors influencing the nature and extent of opioid prescribing in CNMP in primary 
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care. The secondary aim is to develop a theoretical model that describes the relationship 
between factors influencing prescribing of opioids for CNMP by GPs. 
 
Method  
A systematic search was conducted to identify eligible studies followed by a thematic 
synthesis the included studies. Thematic synthesis involves the analysis of primary 
qualitative literature and provides a framework to integrate findings.16 The process is 
reported using the ‘Enhancing transparency in reporting the synthesis of qualitative 
research: the ENTREQ statement, a 21 item checklist.17 The systematic review was 
registered with the International Prospective Register of Systematic Reviews 
(PROSPERO), registration number CRD42017060017. 
  
Search Strategy 
A pre-planned search strategy was devised to identify all available studies on the topic of 
GPs prescribing opioids for chronic non-malignant pain. The inclusion criteria for this 
review were that studies: a) document GP’s experiences and behaviours relating to 
prescribing opioids for chronic non-malignant pain in a primary care setting; b) were 
published in peer-reviewed journals and indexed in key clinical and scientific databases; 
and c) used a qualitative or mixed-method methodology. Studies were excluded from the 
review if they were non-English language, theoretical or methodological articles, policy 
documents, conference abstracts or presentations, as well as studies that focused solely 
on patients’ experiences of opioid prescribing.   
The searches were conducted across a range of medical, pharmacy, and 
psychological databases including MEDLINE, Embase, PsychINFO, Cochrane 
Database, International Pharmaceutical Abstracts, Database of Abstracts of Reviews of 
Effects, CINAHL and Web of Science. These databases were systematically searched 
from 1986, the year of the development of the WHO analgesic ladder to January 2017, 
the search was repeated to identify any relevant papers published from January 2017 - 
February 2018 (the full search strategy is available from the authors on request). Search 
descriptors included chronic pain, opioid, attitude and general practice. We also used 
wildcards as well as multiple versions of these terms, for example chronic non cancer 
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pain, non malignan* pain, opiate and family practice. Reference lists of included articles 
were searched however handsearching was not conducted. The PRISMA flowchart 
summarises the search, review and selection process (Figure 1). 
 
Study Selection 
Two reviewers (MCK & CH) independently screened titles and abstracts of all identified 
references to determine eligibility for inclusion in the review. Inconsistencies in selection 
were examined following review of titles and abstracts. The reviewers then independently 
assessed the full text of the articles. Disagreements were resolved by a third member 
(RD) of the research team. 
 
Quality Assessment 
The quality of the studies was assessed using the Critical Appraisal Skills Programme 
(CASP) tool for qualitative research 18. The CASP checklist highlights the information that 
should be included in a qualitative report and is widely used in qualitative reviews 19. Two 
reviewers (CH & MCK) assessed the quality of each study and a decision on the inclusion 
of studies was made with agreement of all authors.  
 
Data synthesis and analysis 
The results were organised using the process of Thematic Network Analysis (TNA). 20 
TNA is a way of coding, organising and identifying emergent themes in a systematic way. 
The data were coded for basic themes by two researchers (MCK & PP) independently 
and then results were discussed and compared. Initial basic themes described the subject 
of the data extracted and did not attempt to interpret the data 21. All data extracted from 
each paper was indexed and an overarching coding framework developed. All coded 
papers were then reviewed by two researchers (MCK and PP) and where necessary re-
coded in light of the overarching coding framework. Some codes were merged and some 
were broken down into two or more codes as further data nuanced the emergent themes. 
A final check was completed to ensure all codes were used consistently and exhaustively 
for all texts. Codes were then collated by adding different codes and merging similar 
codes. Each code was discussed in relation to the rest and analysed to "identify the 
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underlying patterns and structures" 20. Memo’s and journal entries written during the 
coding were included at this stage to examine the semantic features of each code; 
organising themes were developed through this process. The organising themes were 
then discussed by the two main researchers again and grouped into the global themes of 
the research. Data analysis was conducted using NVIVO Version 11 software. 
 
Results 
The search identified 7020 titles. Excluding duplicates (n=2935), 4085 titles were 
screened; 21 full text articles were reviewed. Thirteen articles were included in the review, 
the characteristics of these studies and associated CASP score are presented in Table 
1. Nine were from the USA, 3 from the UK and 1 from Sweden.  
The basic codes underpinning the organising themes are presented in Table 2. 
Figure 1 provides an overview of the organising and global themes. Some codes were 
incorporated into more than one organising theme.  Some organising themes are included 
in more than one global theme. This intersection of themes is normal and is demonstrative 
of both the close agreement of the papers as to the major issues and the complex nature 
of GP-patient relationships and encounters thus described.  
 
 
Figure 1: Organising and global themes 
 
Suspicion Axis 
This global theme describes the patient, GP and context variables which raise or lower a 
GP’s suspicion of addiction and dependency, substance abuse, criminal activity, health 
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system ‘gaming’ or other misuse of controlled prescription drugs. Factors such as the 
long-standing relationship and continuity of care between a GP and patient, demographic 
patient factors and the presence or absence of a definite diagnosis or aetiology of pain 
all mediate the variables in this axis of decision making.  
 
Trust and mistrust 
This theme was aappeared frequently one across the papers and is about the work the 
GP and the patient must do to gain and keep trust in each other. Characteristics, such as 
expectations of patient’s behavior based on stereotypes, play a part, but so too does the 
history between the patient and GP. Trust is a processual factor in this context, it is built 
over time but can be eroded quickly if a GP feels that the patient is trying to manipulate 
them. The attempt by a patient to obtain opioids is automatically a suspicious act in the 
eyes of the GP. However, a patient in pain seeking relief in this respect will not necessarily 
present differently from one seeking opioids for addiction or dependence. 
 
‘I think everybody’s fingers get burnt with people who you give the opioids to with a more 
trusting attitude than maybe you should have and the problem has quickly come back to 
you with needing more and more opioids.” 22 
 
GPs also doubted the patients’ trust in both themselves and the risk-benefit analysis they 
made about opioid use. The ambiguity of opioids, especially in some communities, 
sometimes put patients off using them even when the GP’s decision was that they would 
be helpful. 
 
“Patients hear the word codeine or some [other opioid] that they recognize and they think 
of it as a street drug, and don’t want to be associated with that. I think in this population, 
when street crime is so rampant, and they have families who have been hurt by street 
crime or family members who are in jail because of selling, patients are very hesitant.” 23 
 
The demographic factors of a patient often changed the doctor’s suspicion that a patient 
might be abusing and/or selling prescription drugs. Generally, GPs reported that they 
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were likely to have less suspicion of misuse in older patients and sometimes racial and 
socio-economic factors also influenced them.  
 
“I think if someone’s history shows that they have an addictive personality, whether it be 
street drugs, alcohol, smoking pot, whatever that theoretical concern is, but the patients 
I’ve used opiates for in non-cancer are nearly always the elderly with joint pain and I don’t 
have any concerns about them, no.” 22 
 
However, many GPs were very aware of this tendency towards demographic stereotyping 
and actively reflected on this to avoid prejudice in their care giving, although their 
assumption was usually towards the negative view that anyone would abuse prescription 
medication. 
 
“That there’s a disconnect, saying, my brain wants to say…what we teach the residents… 
[that] anybody on narcotics [should have an OTA], even if it’s the sweetest little 85-year-
old woman who looks like your grandmother, versus, you know, some guy from the ghetto 
wearing his pants down at his knees… it shouldn’t really matter” . 24 
 
Importance of aetiology 
The recognition of the difficulties inherent in subjective pain assessment is at the heart of 
the GP decision making process. A diagnosed etiology helped a GP to feel more confident 
in the patient’s reports of pain, but even then, the extent of the pain was hard to gauge. 
 
“Pain is so subjective and so that’s where the difﬁculty lies . . . I ﬁnd it hard to say how 
someone’s pain can be judged by someone else.” 25 
 
The importance of an aetiology of the patient’s pain was a critical factor in the GP’s level 
of suspicion of abuse or aberrant prescription use. For patients who did not have an easily 
identifiable pathology, this led to difficulties for the GPs in managing their reported pain. 
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“I feel this as a physician, when I see a patient who has, you know, a pathological fracture 
on an X-ray... if there’s something objectively definable it does change the way that I 
approach the patient.” 26 
 
Risk Axis  
GPs conduct a risk-benefit analysis when deciding to initiate or continue a prescription 
for opioids. Three crucial elements in this decision making are the harm to the patient, the 
harm to society and the harm to the GP themselves in terms of feelings of guilt and even 
the fear of professional sanctions should an incident occur. 
 
Physical and psychological harm 
Many of the GP’s explicitly discussed the fact that they would prioritise risk avoidance 
over adequate pain relief. This is demonstrative of the ‘devil and deep blue sea’ 
conundrum that GPs face: the potentially devastating effects of addiction mean that 
adequate management of pain, a key professional obligation, is not possible. 
 
“For chronic pain in someone with a non-terminal type of illness you’ve got to weigh up 
what you are giving them in the long term, what are the potential side effects, is there an 
issue with addiction and you’re not going to just be increasing … For chronic pain, non-
malignant pain, I think there has to be an acceptance that you are not necessarily going 
to get them pain free because they’ve got the rest of their lives to live as well … so your 
two end points are different.” 22 
 
Related to the fear of causing harm was the guilt some physicians experienced, or might 
experience, due to opioid-related adverse events, causing them to think carefully before 
issuing a prescription: 
 
“If something does happen to them, you feel guilty and want to crawl under a table when 
they’re in the emergency room and you get the call that they fell while on the fentanyl 
patch you gave them. That kind of experience is powerful and definitely factors into the 
equation.” 23 
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Many GPs worried about the effect of frailty in their elderly patients, because of the much 
higher risks of side-effects or accidental injury. However, they also worried less about 
addiction in much older patients so the risk axis is complex to negotiate for frail patients. 
 
“I just have a hard time prescribing opioids in my older patients. I get frightened with 80+ 
year olds; how are they going to respond? Am I going to absolutely drop them to the floor 
even with a small dose?” 23 
 
Patients with physical and mental illnesses in addition to their chronic pain were seen as 
particularly hard to prescribe for because of the difficulties in predicting their likely 
response to opioids and also their risk of becoming addicted. Some GPs saw addiction 
as a psychiatric co-morbidity in and of itself, and the resultant confusion about how to 
both manage pain with addictive substances and treat the addiction itself were very 
apparent.  
 
Morality of addiction 
The nature of the drug itself, its addictive qualities but also its situation in the moral and 
legal ambiguity as a controlled substance given for a more or less valid reason, changed 
the nature of the GP-patient relationship. 
 
 “In most doctor–patient relationships we learn to listen to the patient and accept their 
testimony ... in some instances [in opioid prescription consults], to be quite honest, we 
are interviewing the patient as if we are a police officer or a lawyer and we’re trying to find 
flaws in their story ... So, there is a different relationship here.” 26 
 
Disagreement Axis  
This global theme concerns the level of agreement between patient and physician about 
the prescribing outcome from the consultation. Whether the patient is given opioids or not 
is not relevant to this axis, it is more concerned with the patient and GPs’ mutual 
acceptance or conflict about the final management plan. Factors such as previous 
Commented [MK1]: This needs development 
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relationship with the patient as well as the factors discussed above in the suspicion axis, 
influence the likelihood of GP/patient agreement but it is worth noting that the necessity 
to preserve trust itself did often lead GPs to make prescriptions that they were otherwise 
concerned about. Trust in a GP patient relationship is crucial to any effective management 
plan, but all of the GPs who discussed it hinted that it was easily disrupted. Again, this 
also links back to the importance of an identified aetiology, which at least gave the GP 
confidence that a prescription was necessary. 
 
‘‘I don’t know what the pain is like. They really might be in pain. I don’t want to challenge 
them and have them think that I don’t trust them. I don’t want to make them any more 
miserable.’’ 27 
 
It is perceived as difficult for a GP to distinguish between drug seeking behaviour and 
pain relief seeking behaviour and this is at the core of the anxiety and conflict in the use 
of opioids for pain management. The way in which a patient presents has a huge influence 
on how much trust there is during the consultation and therefore on how likely the patient 
and GP are to agree on a management plan. Some of the physician’s demonstrated much 
empathy for a patient in pain, but this empathy when coupled with a lack of options for 
managing CNMP means that inappropriate prescriptions are more often given. This is not 
to suggest that the pain shouldn’t be treated but that the limited options for CNMP 
available in most primary care settings leave physicians with few options. 
 
“You have to show a patient you you’re empathetic to him. There is a pain. Pain is real” 
25 
 
However, by displaying empathy, trust is developed and it may perhaps be easier to reach 
treatment agreements which are not always opioid prescriptions when such avenues of 
therapy are appropriate and available. 
 
“There are people who have expressed an interest to me in not wanting to be on the 
medication any more. Some have admitted that they’re probably at some level of 
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dependence or addiction and we have had open discussions about not wanting to need 
this medication anymore.’’ 27 
 
System Level Factors 
This global theme describes the context and influences on the GP, patient and clinic. 
Whilst these variables change over time, they do not change in the duration of the consult 
itself and are therefore the static parameters in which the consultation occurs. Some of 
the basic themes within this were universal, that is they applied to all countries and types 
of practice setting, such as the GP identified need for education and training on opioid 
prescribing. Some were specific to certain models of healthcare, for example, in the USA 
only certain patients who had the correct type of insurance could reliably attend a pain 
clinic, which made patients without such insurance more problematic for GPs to manage 
as there was no external support. 
 
Across all countries, GPs worried that their prescribing practices were based on a ‘woolly’ 
conglomeration of their previous experiences without any external guidelines on which to 
base their decisions.  
 
‘I suppose, the way I behave now prescribing for everything is a sort of rather woolly, 
nebulous product of everything I’ve done, particular experiences of dealing with pain.’ 22 
 
Some GP’s had specialist training in pain management as part of their initial training, but 
many felt like they were inadequately prepared and questioned the wisdom of leaving 
generalist primary care specialists to negotiate such a complex and potentially risky 
prescription management. 
 
‘‘It’s a mistake promoting doctors like me to [treat pain and addiction]. It would be a 
societal mistake to have addiction and pain medicine be managed without other support 
services... Most of us in primary care end up [doing it] by default. But that’s not good. 
That’s not something to be promoted.’’ 27 
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Another reason for the perceived inadequate preparation of GP’s for opioid prescription 
management is the scarcity of time and resources as the health systems of the USA and 
the UK become ever more stretched. A lack of training was identified across all settings, 
with many of the GP’s feeling that they had training needs in opioid and pain prescription 
management. 
 
“I think it’s [anxiety about what to prescribe] just due to lack of experience with using 
opioids for non-malignant pain... and because I haven’t really done a lot of palliative care 
either.” 28 
 
A lack of time to properly assess a patient and their pain needs were identified by GPs.  
 
“The biggest problem in the whole thing is lack of time. Typically, these are complex 
people with multiple problems, and you really could spend the whole appointment, more 
than 1 whole appointment, just talking about this [opioid agreement]. I mean, we have all 
these reminders that we have to do, and all the scripts, and they’re wanting a podiatry 
consult, and an eye consult, and you need to really sit down and go through a person’s 
record, and really try to make a more rational decision. I take it very seriously. It’s serious 
business. What if you do create an opiate problem for somebody? Because you’re not 
being careful enough about it?” 29 
 
Further, a lack of specialist and joined-up support for both addiction and pain 
management was identified as a failure of the systems, again in all settings. 
 
‘‘There is a really big access issue with the pain clinics right now, for patients with Title 
19 [Medicaid], and most of my patients are Title 19. So, while I can refer them, their 
likelihood of getting an appointment, even with strong advocacy from me, is very low.” 27 
 
Many of the discussions about individual prescriptions also opened out to consideration 
of the wider issues in prescription opioid dependence and societal harm. Opioid 
prescriptions are subject to specific legislation, in most countries strong opioids are a 
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controlled substance, primarily due to their association with misuse. Due to these tight 
controls on their availability, opioids, particularly the more potent drugs, can have a high 
monetary value in illegal sale and usage.  
 
“We have a responsibility to be careful with prescribing these medications, so when we 
get burned, society gets burned, patients get burned.” 26 
 
Monitoring appears in all four global categories and is such a cross cutting theme as GPs 
attempt to improve their management of CNMP and to ameliorate harm at both the patient 
and societal levels. GPs used contracts, sometimes to support their management and 
other times because they felt it was expected of them. There was much ambiguity around 
the use of contracts and a recognition that, whilst they could be useful, they also had the 
potential to damage the fragile patient-GP trust relationship. 
 
“The contract I really use so that it formalizes our relationship.it makes it easier if you 
have to take it to the next step and make this referral [to substance use disorder 
treatment].”27  
 
Many GPs thought that this change to the relationship was not productive and felt that it 
ran counter to the trust-based nature of their roles.  
 
“I think [drug screening is] destructive to a basic patient-doctor relationship. You’re there 
to help them and they can tell you their deepest, darkest secrets, but yet you’re policing 
them.  29” 
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Figure 2: Theoretical framework: Risk, suspicion and disagreement axes interact to shape the 
opioid prescribing decisions. These are also influenced by system level factors which are seen to 
encompass these other variables. 
 
Theoretical Model 
Through synthesis of basic themes to organising themes then global themes, an 
overarching theoretical model was developed (Figure 2). The model proposes that when 
faced with a decision to prescribe an opioid for a patient with CNMP, the GP, operates 
within this framework. The decision to prescribe is informed by the perceived or actual 
risks associated with prescribing an opioid for the patient, both physical and 
psychological, the risk axis (Y-axis). This is balanced with the credibility of the pain 
complaint combined with the likelihood of developing aberrant drug behaviours, the 
suspicion axis (X-axis). At the centre of the decision-making process therefore is 
ingrained the GPs understanding of the physical, psychological and moral qualities of the 
patient, the credibility of their pain condition and potential for opioid misuse offset against 
the therapeutic appropriateness of the prescription. This is further balanced with the 
expectations of both parties in the consultation, the GP and the patient, the disagreement 
axis (Z-axis). If both parties agree about the desired outcome of the consultation, the 
issuing of an opioid prescription, is a fait accompli in that consultation. The healthcare 
system and legislative requirements relating to opioid prescriptions provide an inflexible 
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environment in which the consultation takes place, the system level factors. System level 
factors will not only differ for GPs internationally but on a regional and practice level basis. 
 
Discussion 
This study has reviewed the factors affecting the prescribing of opioids for CNMP by GPs 
in primary care. By integrating the findings of the qualitative literature on this subject and 
deriving a theoretical model, we hope to progress the discussion on this subject, from one 
which seeks to map factors related to opioid prescribing to one which seeks to provide 
practical solutions. As GPs are responsible for the burden of care, it is imperative that the 
dynamics of opioid prescribing specific to primary care are mapped in order to identify 
practice changes that are of direct relevance to GPs.  
The theoretical model that has been derived from the metasynthesis proposes that 
the factors underpinning the decision to prescribe are not weighted against each other in 
a risk/benefit equation as previously hypothesised in the literature. 30 Rather, it is 
proposed, that factors, in this case modelled as global themes, interact to affect the 
likelihood of a prescribing outcome. For example, a young healthy patient with no co-
morbidities presents less risk than a multimorbid older patient. However, the younger 
patient may trigger concern for the GP if actively requesting a prescription for an opioid 
particularly in the absence of a defined aetiology. Therefore, the younger patient, while 
low on the risk axis will be higher on the suspicion axis. The likelihood of being prescribed 
an opioid will be further diminished if the patient and GP are unable to reach a shared 
understanding of the analgesic management plan for the patient.  
Opioids, although a highly effective family of analgesics, have a unique set of 
considerations that inform their use, the legal constraints surrounding their prescription 
and supply due to their potential for abuse and misuse, the side-effects of these 
medications together with their ill-defined benefits when used in the long-term. 31 These 
issues attach an element of stewardship to the prescribing of these agents, shifting the 
task to the more complex end of the prescribing spectrum. The legal constraints and 
policy recommendations guiding the prescribing of opioids are akin to antibiotic 
stewardship. However, while we seek to manage antibiotic resistance on a public health 
level, the very real issues of mortality and morbidity with endemic opioid misuse is usually 
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discussed as it pertains to an individual’s behaviour. In practice, this moral construct 
obfuscates the real core of the current opioid crisis, which is that of a very small number 
of widely available options in chronic pain management and adequate pain control. The 
morality which is embedded within discussion of opiate use, but also rarely discussed, 
also leaves little room for discussion of the non-pathophysiological causes of pain and 
the complex relationship between mental health and CNMP. 
A more objective and holistic view of a patients with CNMP, especially that pain 
which does not have a discernible aetiology, would perhaps lead to more psychological 
and physiotherapeutic interventions which currently are endorsed by the literature and 
within guidelines but are not realistic treatment pathways for all patients 31. There is no 
doubt from the literature that pain control is a life changing intervention for many patients, 
but the risk benefit analysis of using opioids to this end is not often done in an objective 
way because of the attendant moral concerns around this class of drugs. Further, issues 
of health inequality are also often obscured by the morally loaded discussions around the 
opioid crisis. Patients who are of low socioeconomic position are at once more likely to 
experience untreated physical injuries and illnesses, more likely to have mental illnesses 
which contribute to or cause presentations of CNMP and are less likely to be managed in 
specialist facilities. 32 Thus, the burden of mortality is skewed towards the most 
vulnerable, towards those most likely to have pain and to be poorly managed within that 
pain. This fact needs to be part of the discussion too, as it is in and of itself an issue of 
morality and without a consideration of this in planning novel interventions, we will not 
target the people most in need. 
Increasingly, recommendation within the literature is for GPs to not prescribe any 
opioids except for palliative care. 31, 33 Such a change in prescribing strategies is 
significant shift from current practices and perhaps oversimplifies the solution to the opioid 
epidemic. Furthermore, this advice is not helpful for those GPs caring for patients already 
established on an opioid regimen with opioid tapering a resource intensive and 
challenging process. Such a stance is also challenging in the context of a healthcare 
system with limited access to specialised care and where the cost of non-pharmacological 
interventions is not subsidised by the healthcare system or cannot be met by the individual 
alone. 
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Strengths and Limitations 
The thematic review was conducted systematically and methodically, with each stage of 
the research being validated by at least two authors however, it is possible that other 
interpretations may be derived from the papers included in the review. A systematic 
approach was taken to identify papers and the search was conducted by an experienced 
librarian. However, only papers that were published in peer-reviewed journals were 
identified as the search did not extend to grey literature. Studies included in the review 
were of variable quality following appraisal using the CASP tool. Only one study 
addressed researcher reflexivity although those papers that did not document their 
approach in relation to reflexivity were included. Methodologically the papers were similar, 
most utilised unstructured or semi-structured but in-depth interviews with GP’s within a 
standard non-theory based qualitative approach.  
 
Conclusion  
The prescribing of opioids for CNMP by GPs is influenced by factors relating to the 
specific patient, the consultation, experiences and perceptions of the prescriber as well 
as the healthcare system in which the GP operates. Rather than a relatively linear risk-
benefit relationship, there is a complex interaction between these various factors which 
affect the likelihood of a prescription being issued. The implicit morality judgment that is 
associated with the use of opioids is a key factor that is perhaps unique to this class of 
drugs. Current policy recommendations directed at GPs oversimplify the complex process 
underpinning the initiation or continuation of opioids in primary care, it is therefore 
unsurprising that increasing trends in opioid prescriptions have remained stubbornly 
consistent.  
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Table 1: Characteristics of included studies 
Study Geographical 
Location 
Methods Participants Data Collection Aim Key Themes CASP score 
(max 10) 
Barry et al., 
2010 
USA Grounded 
theory 
using 
constant 
comparativ
e method 
for 
systematic 
inductive 
analysis 
23 office based 
physicians 
(13 women, 10 
men) 
Semi-structured 
interviews 
Identify barriers and facilitators to 
opioid treatment of chronic non 
cancer pain patients by office 
based medical providers 
Three key themes which were 
further subdivided into subthemes: 
Physician factors 
Patient factors 
Logistical factors 
8 
Bendtsen et al., 
1999 
Sweden Critical 
incident 
technique 
114 physicians 
(general 
practitioners and 
general practice 
registrars) 
Semi-qualitative: 
questionnaire 
Explore the qualities of dilemmas 
and considerations among 
physicians prior to deciding 
whether or not to prescribe opioid 
analgesics to patients in a 
primary care healthcare setting 
Concern about abuse and addiction 
with no proper indication for the drug 
  
Indication for the drug – acute or 
chronic pain 
8 
Bergman et al., 
2013 
USA Inductive 
thematic 
analysis 
14 Primary care 
practitioners 
26 patients with 
chronic pain 
One-time in 
depth interviews 
Develop a better understanding  
of the respective experiences, 
perceptions and challenges that 
patients with chronic pain and 
PCPs face communicating with 
each other about pain 
management 
Role of discussing pain versus other 
primary care concerns 
Acknowledgement of pain and the 
search for objective evidence 
Recognition of patient individuality 
and consideration of relationships 
9 
Esquibel and 
Borkan, 2014 
USA Immersion/
crystallisati
on process 
generate a 
thematic 
codebook 
16 physicians Patient-
physician dyads 
(interviews) 
To explore the ways in which 
opioids medication influence the 
doctor-patient relationship 
Pain considered as a 
biopsychosocial model 
Challenges to legitimise and treat 
non-objective pain 
Chronic opioid therapy is not the 
preferred pain management modality 
10 
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Feeling inadequate as a care 
provider in treating pain 
Pain relied many not be a top health 
priority 
Gooberman-Hill 
et al., 2011 
UK Thematic 
analysis 
27 GPs 
(13 men, 14 
women) 
Semi-structured 
interviews 
To explore GPs’ opinions about 
opioids and decision-making 
processes when prescribing 
‘strong’ opioids for chronic joint 
pain 
Are opioids the best option 
Managing adverse effects and 
assessing vulnerable patients 
Views about opioid addiction, 
withdrawal and misuse 
Importance of previous experience 
10 
Harle et al., 
2015 
USA Open 
coding 
thematic 
analysis 
15 family medicine 
and general 
medicine 
physicians (7 men, 
8 women) 
In-depth 
interviews 
To understand how primary care 
physicians perceive their 
decisions to prescribe opioids in 
the context of chronic noncancer 
pain management 
Physicians’ information needs and 
use 
- Importance of objective and 
consistent information 
- Importance of identifying 
‘red flags’ related risks to 
prescribing opioids 
- Importance of information 
about physical function and 
outcome goals 
- Importance of tacit 
knowledge and trust in 
patients 
Other decision making challenges 
related to opioids 
- Weighing potential 
therapeutic benefits against 
opioid risks 
- Time and resource 
constraints 
- The role of primary care 
specialties in managing 
pain 
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Krebs et al., 
2014 
USA Qualitative 
immersion/
crystallisati
on 
approach 
14 primary care 
physicians 
(recruited from 5 
primary care 
clinics) 
Semi-structured 
interviews 
Understand physicians’ and 
patients’ perspectives on 
recommended opioid 
management practices and to 
identify potential barriers to and 
facilitators of guideline-
concordant opioid management in 
primary care 
Three barriers to use of 
recommended opioid management 
practices: 
Inadequate time and resources for 
opioid management 
Relying on general impressions of 
risk for opioid use 
Viewing opioid monitoring as a law 
enforcement activity 
10 
Matthias et al., 
2010 
USA Thematic 
analysis 
20 (10 men, 10 
women from 5 
outpatient primary 
care clinics) 
Semi-structured 
interviews 
To elicit provider’s perspectives 
on their experiences in caring for 
patients with chronic pain 
Providers emphasised the 
importance of the patient-provider 
relationship asserting that productive 
relationships with patients are 
essential for good pain care 
Detailed difficulties they encounter 
when caring for patients with chronic 
pain including feeling pressurised to 
treat with opioids 
10 
Matthias et al., 
2013 
USA Emergent 
thematic 
analysis 
5 (3 female, 2 
male)(veteran 
affairs primary 
medical centre) 
Recording of 
consultations 
with patients 
Understand how physicians and 
patients with chronic 
musculoskeletal pain 
communicated about issues 
related to opioids 
Uncertainties about opioid treatment 
for chronic pain, particularly 
addiction and misuse 
10 
McCrorie et al., 
2015 
UK Grounded 
theory 
approach 
15 GPs (11 
women, 4 men) 
Focus groups Understand the processes which 
bring about and perpetuate long-
term prescribing of opioids for 
chronic, non-cancer pain 
Organisation of UK general practice 
Available therapeutic options 
Expertise in managing chronic pain 
10 
Seamark et al., 
2013 
UK Thematic 
analysis 
17 (interviews) 
5 (focus group) 
Semi-structured 
interviews 
Focus group 
To describe the factors influencing 
GPs’ prescribing of strong opioid 
drugs for chronic non-cancer pain 
Chronic non-cancer pain is seen as 
different from cancer pain 
Difficulties in assessing pain 
Effect of experience and events 
 
Spitz et al., 2011 USA Directed 
content 
analysis 
23 physicians Six focus groups Describe primary care providers’ 
experiences and attitudes 
towards, as well as perceived 
barrier and facilitators to 
prescribing opioids as a treatment 
for chronic pain among older 
adults 
Fear of causing harm 
Pain subjectivity 
Concerns about regulatory and/or 
legal sanctions 
Perceived patient- level barriers to 
opioid use 
Greater comfort in using opioids in 
palliative care 
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Frustration treating pain in primary 
care 
Starrels et al., 
2014 
USA Grounded 
theory 
approach 
28 primary care 
providers (18 
women, 10 men) 
Semi-structured 
telephone 
interviews 
To determine primary care 
providers’ experiences, beliefs 
and attitudes about using opioid 
treatment agreements for patients 
with chronic pain 
Perceived effect of OTA use on the 
therapeutic alliance 
Beliefs about the utility of OTAs for 
patient or providers 
Perception of patients’ risk for opioid 
misuse 
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Search Flow Diagram 
 
 
 
  
Records identified through 
database searching 
(n = 7020  ) 
Records after duplicates removed  
(n = 4085 ) 
Records screened  
(n = 4085) 
Records excluded  
(n = 4064) 
Full-text articles 
assessed for eligibility  
(n = 21) 
Full-text articles excluded:  
(n = 8) 
 
Insufficient qualitative data 
(n=4) 
Focus on specific disease 
state (n=1) 
Not specifically GPs- included 
other primary care prescribers 
(n=3) 
Studies included in 
quantitative synthesis 
(meta-analysis)  
(n = 13) 
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Table Basic codes, organising and global themes 
Suspicion Axis Risk Axis Disagreement Axis System Level Factors 
Trust and mistrust 
I’m not abusing anything – 
the fine line between pain 
control and abuse 
Medical or psychiatric 
comorbidity 
Undiagnosed focus or 
cause 
Disruptive influence of 
substance use disorder 
Psychological or non-pain 
reasons to take opioids 
Health system gaming – 
benefits insurance and 
selling prescriptions 
If you can’t see the dilemma 
in this situation 
Patient asking for opioids 
and losing physicians 
respect 
Demographics, stigma and 
stereotyping 
Aberrant medication use 
 
Importance of aetiology 
Objective pain assessment 
Appropriate indication – 
arising from objective 
evidence 
Medical or psychiatric 
comorbidity 
Undiagnosed focus or 
cause assumption of abuse 
 
Monitoring 
Assessment 
Patient frustration with 
inadequate pain 
management 
Drug testing and contracts 
Monitoring 
Physicians concerns for 
side-effects and addiction 
Follow up and review 
Adverse effects 
Disruptive influence of 
substance use disorder 
Aberrant medication use 
 
Physical and 
psychological harm 
Physicians concern for side 
effects and addiction 
If you can’t see a dilemma 
in this situation 
Aberrant medication use 
Medical or psychiatric 
comorbidity 
 
The morality of addiction 
If you can’t see the 
dilemma in this situation 
I’m not abusing anything – 
the fine line between pain 
control and abuse 
Health systems gaming – 
benefits, insurance and 
selling prescriptions 
Patient asking for opioids 
and losing physician 
respect 
Drug testing and contracts 
 
Monitoring 
Assessment 
Patient frustration with 
inadequate pain 
management 
Drug testing and contracts 
Monitoring 
Physicians concern for 
side-effects and addiction 
Follow up and review 
Adverse effects 
Disruptive influence of 
substance use disorder 
Aberrant medication use 
Consult variables 
Managing pain and opioid 
conversations 
Physician guilt and 
maintaining trust 
Physician frustration with 
patient 
Patient influences 
Prescribing practices 
Empathy 
Consultation 
Assessment 
Patient frustration with 
inadequate pain 
management 
Adverse effects 
Physician concern for side-
effects and/or addiction 
Patient asking for opioids 
and losing patient respect 
Demographics, stigma and 
stereotyping 
Disruptive influence of SUD 
Knowledge and training 
Lack of clinical guidelines – 
woolly 
Service limitations, time and 
resources 
Inadequate pain 
management 
Patient frustration with 
inadequate pain 
management 
I’m not abusing or anything 
– the fine line between 
pain control and abuse 
 
Systems 
Lack of clinical guidelines – 
woolly 
Service limitations, time 
and resources 
Cost and expense 
Law enforcement and 
rationing 
Lack of training 
Knowledge and training 
Health system gaming – 
benefits, insurance and 
selling prescriptions 
If you can’t see the 
dilemma in this situation 
Patient asking for opioids 
and losing physician 
respect 
Disruptive influence of 
substance use disorder 
 
Monitoring 
Drug testing and contracts 
Disruptive influence of 
substance use disorder 
Aberrant medication use 
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